- Home
- LRMR vs NXDT Comparison
LRMR vs NXDT Comparison
Compare LRMR & NXDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- NXDT
- Stock Information
- Founded
- LRMR N/A
- NXDT 2012
- Country
- LRMR United States
- NXDT United States
- Employees
- LRMR N/A
- NXDT N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- NXDT Investment Managers
- Sector
- LRMR Health Care
- NXDT Finance
- Exchange
- LRMR Nasdaq
- NXDT Nasdaq
- Market Cap
- LRMR 204.9M
- NXDT 192.3M
- IPO Year
- LRMR N/A
- NXDT N/A
- Fundamental
- Price
- LRMR $3.88
- NXDT $4.87
- Analyst Decision
- LRMR Strong Buy
- NXDT
- Analyst Count
- LRMR 7
- NXDT 0
- Target Price
- LRMR $17.86
- NXDT N/A
- AVG Volume (30 Days)
- LRMR 892.3K
- NXDT 133.6K
- Earning Date
- LRMR 08-06-2025
- NXDT 01-01-0001
- Dividend Yield
- LRMR N/A
- NXDT 9.66%
- EPS Growth
- LRMR N/A
- NXDT N/A
- EPS
- LRMR N/A
- NXDT 0.99
- Revenue
- LRMR N/A
- NXDT N/A
- Revenue This Year
- LRMR N/A
- NXDT N/A
- Revenue Next Year
- LRMR N/A
- NXDT N/A
- P/E Ratio
- LRMR N/A
- NXDT $6.41
- Revenue Growth
- LRMR N/A
- NXDT N/A
- 52 Week Low
- LRMR $1.61
- NXDT $5.89
- 52 Week High
- LRMR $9.88
- NXDT $13.07
- Technical
- Relative Strength Index (RSI)
- LRMR 69.65
- NXDT 57.33
- Support Level
- LRMR $3.11
- NXDT $4.78
- Resistance Level
- LRMR $4.01
- NXDT $5.26
- Average True Range (ATR)
- LRMR 0.27
- NXDT 0.30
- MACD
- LRMR 0.03
- NXDT 0.00
- Stochastic Oscillator
- LRMR 85.64
- NXDT 54.65
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About NXDT NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.